Schneider, Miklos http://orcid.org/0000-0003-1488-4743
Bjerager, Jakob http://orcid.org/0000-0002-6620-6242
Hodzic-Hadzibegovic, Delila
Klefter, Oliver Niels http://orcid.org/0000-0003-2313-5648
Subhi, Yousif http://orcid.org/0000-0001-6620-5365
Hajari, Javad
Funding for this research was provided by:
National Hospital
Article History
Received: 8 January 2024
Revised: 8 January 2024
Accepted: 14 February 2024
First Online: 28 February 2024
Declarations
:
: The research and data handling were conducted in compliance with local laws, the tenets of the Declaration of Helsinki and its amendments. Based on the decision of the Regional Ethics Committee of the Capital Region of Denmark, the study protocol was exempt from institutional review board approval, as the research involved retrospective data collection from routine clinical procedures within indication (case nr.: F-23059408, date of decision: 01/11/2023). The Research Legal Department of the Capital Region of Denmark has approved the patient confidentiality and data flow protocol of the project (approval nr.: p-2023–14984, date of decision: 03/11/2023). The study protocol was registered at ClinicalTrials.gov, registration number: NCT06124677, date of registration: 09/11/2023.
: The patient whose optical coherence tomography scans were used in this publication as representative case, provided written informed consent for the publication of the images.
: Author MS declares to have served as an advisory board member for Novartis and Roche and acted as consultant for AbbVie, and received travel grants from AbbVie and Roche, not related to this work. Author DHH declares to have served as an advisory board member for Roche, not related to this work. Author YS declares to have received speaker fees from Bayer and Roche, not related to this work. Authors JB, ONK, and JNH declare that no potential conflicts of interests exist in relation to this work.